Lacutamab Clinical Trial for Certain CTCL Patients

Innate Pharma has recently announced phase 2 of a clinical trial dubbed TELLOMAK regarding the investigative drug lacutamab (IPH4102), an anti-KIR3DL2 monoclonal antibody, alone or in combination with chemo. The focus of this study is the treatment of patients with the rare cutaneous t-cell lymphoma (CTCL) Mycosis Fungoides and it’s systemic comparable Sézary Syndrome. The…… Continue reading Lacutamab Clinical Trial for Certain CTCL Patients

Personal Protective Equipment From My Storage Chest

The other day I was rummaging around a storage chest for an old book I needed to consult in a current work project. I won’t go into the details of the book – nothing too exciting, I assure you. As I dug through my storage toward the target book, I ran across a small box…… Continue reading Personal Protective Equipment From My Storage Chest

Swelling (Lymphedema) and Cancer

As the title suggests, lymphedema is swelling. It usually occurs when lymph nodes are removed or the lymphatic system is damaged in some way. Damaged or blocked lymph nodes are unable to process the lymph (lymphatic fluid) that flows throughout our bodies normally, and the liquid begins to collect. Thus, we get swelling. How is…… Continue reading Swelling (Lymphedema) and Cancer